Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | BMY | MRNA | AMGN | GILD |
| Company | Aslan Pharmaceuticals Ltd ADR | Bristol-Myers Squibb Company | Moderna Inc | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4200 | 43.56 | 123.15 | 309.53 | 65.18 |
| High | 0.4201 | 43.98 | 125.50 | 311.24 | 65.22 |
| Low | 0.3924 | 43.50 | 121.68 | 306.32 | 64.66 |
| Last | 0.4189 | 43.88 | 124.30 | 311.52 | 64.66 |
| Change | +0.0164 | +0.21 | +2.41 | +4.21 | -0.26 |
| % Change | +4.07% | +0.48% | +1.98% | +1.37% | -0.40% |
| Volume | 210,475 | 2,551,276 | 1,032,693 | 697,646 | 1,381,781 |
| 20-Day Average Volume | 923,611 | 13,936,016 | 3,190,581 | 2,791,198 | 7,217,794 |
| Previous Close | 0.4025 | 43.67 | 121.89 | 307.31 | 64.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4613 | 46.13 | 111.39 | 279.37 | 66.11 |
| 20-Day Raw Stochastic | 7.46% | 8.54% | 82.55% | 81.09% | 10.52% |
| 20-Day Relative Strength | 42.40% | 30.24% | 64.97% | 67.32% | 32.35% |
| Weighted Alpha | -92.27 | -36.45 | +11.15 | +34.47 | -21.28 |
| Today's Opinion | 88% Sell | 100% Sell | 100% Buy | 56% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 100% Sell | 100% Buy | 56% Buy | 100% Sell |
| Last Month's Opinion | 40% Sell | 48% Sell | 88% Buy | 40% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.11% since 05/02/24 | +0.38% since 05/02/24 | -1.54% since 05/02/24 | +11.67% since 05/02/24 | -0.84% since 05/02/24 |
| Low | 0.3924 on 05/09/24 | 43.49 on 05/09/24 | 118.68 on 05/07/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 |
| High | 0.4745 on 05/03/24 | 44.62 on 05/06/24 | 126.40 on 05/03/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 |
| 1-Month | |||||
| %Chg | -28.28% since 04/09/24 | -14.99% since 04/09/24 | +10.81% since 04/09/24 | +14.99% since 04/09/24 | -7.38% since 04/09/24 |
| Low | 0.3924 on 05/09/24 | 43.33 on 05/02/24 | 99.30 on 04/22/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 0.6121 on 04/22/24 | 51.28 on 04/10/24 | 128.81 on 05/02/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 |
| 3-Month | |||||
| %Chg | -25.67% since 02/09/24 | -11.94% since 02/09/24 | +41.47% since 02/09/24 | +6.79% since 02/09/24 | -12.07% since 02/09/24 |
| Low | 0.3924 on 05/09/24 | 43.33 on 05/02/24 | 84.06 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 2.0900 on 03/12/24 | 55.03 on 03/13/24 | 128.81 on 05/02/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 |
| 6-Month | |||||
| %Chg | -62.32% since 11/09/23 | -12.98% since 11/09/23 | +77.90% since 11/09/23 | +17.73% since 11/09/23 | -13.60% since 11/09/23 |
| Low | 0.3920 on 12/26/23 | 43.33 on 05/02/24 | 67.62 on 11/13/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 |
| High | 2.0900 on 03/12/24 | 55.03 on 03/13/24 | 128.81 on 05/02/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,581 | 88,523,448 | 46,713,120 | 164,851,840 | 80,830,400 |
| Shares Outstanding, K | 16,350 | 2,027,100 | 383,240 | 536,435 | 1,245,077 |
| Annual Sales | 12,000,000 | 45,006,000,000 | 6,848,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -44,220,000 | 8,025,000,000 | -4,714,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 11,865,000,000 | 167,000,000 | 7,447,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -9,710,000 | -11,911,000,000 | -1,175,000,000 | -113,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.52 | 0.45 | 1.57 | 0.60 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.78 on 04/12/24 | -4.40 on 04/25/24 | -3.07 on 05/02/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/10/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | N/A | 05/16/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.94 | 0.00 | 16.12 | 16.24 |